DaVita Inc. to Participate in UBS Global Healthcare Conference 2024
DaVita Inc. to Participate in UBS Global Healthcare Conference 2024
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of September 30, 2024, DaVita served approximately 265,400 patients at 3,113 outpatient dialysis centers, of which 2,660 centers were located in the United States and 453 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.DENVER, Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at UBS Global Healthcare Conference 2024 on Tuesday, November 12, 2024 at 12:30 pm PST (3:30 pm EST).
丹佛，2024年11月8日/美通社/ -- 德維特公司（紐交所：DVA）今天宣佈，其首席財務官喬爾·阿克曼和投資者關係集團副總裁尼克·埃裏森將於2024年11月12日星期二下午12:30在UBS 2024全球醫療保健大會上與投資者進行一場座談會（PSt時間，下午3:30 EST時間）。
To view the live webcast, visit the UBS page here and create a free registration.
要觀看現場網絡轉播，請訪問這裏的UBS頁面並創建免費註冊。
About DaVita Inc.
關於德維特公司
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of September 30, 2024, DaVita served approximately 265,400 patients at 3,113 outpatient dialysis centers, of which 2,660 centers were located in the United States and 453 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
德維特（NYSE：DVA）是一家專注於改善全球患者生活質量的醫療保健提供商。作爲綜合腎臟護理提供商，德維特在臨床質量和創新方面已經領先20多年。德維特護理着患者在腎臟健康旅程的每個階段和環境中——從減緩腎臟疾病進展到幫助支持移植，從急性醫院護理到家庭透析。截至2024年9月30日，德維特在3113家門診透析中心中爲約265,400名患者提供服務，其中有2,660家中心位於美國，453家位於全球13個其他國家。德維特減少了住院次數，提高了生存率，並在推動腎臟護理行業共同努力，以爲全球所有患者制定公平和高質量的護理標準。欲了解更多信息，請訪問DaVita.com/About。
Contact Information
[email protected]
聯繫信息
[email protected]
SOURCE DaVita
消息來源：德維特公司
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎？
譯文內容由第三人軟體翻譯。
